Characterization of Three CYP2C19 Gene Variants by MassARRAY and Point of Care Techniques: Experience from a Czech Centre-Reference-Cited by-同舟云学术

Characterization of Three CYP2C19 Gene Variants by MassARRAY and Point of Care Techniques: Experience from a Czech Centre

Published:2016-12 Issue:S1 Volume:64 Page:99-107
ISSN:0004-069X
Container-title:Archivum Immunologiae et Therapiae Experimentalis
language:en
Short-container-title:Arch. Immunol. Ther. Exp.

Author:

Petrek Martin^ORCID,Kocourkova Lenka,Zizkova Veronika,Nosek Zdenek,Taborsky Milos,Petrkova Jana

Funder

Univerzita Palackého v Olomouci

MSMT CR

Publisher

Springer Science and Business Media LLC

Subject

General Medicine,Immunology,Immunology and Allergy

Link

http://link.springer.com/content/pdf/10.1007/s00005-016-0440-8.pdf

Reference31 articles.

1. Beitelshees AL (2012) Personalised antiplatelet treatment: a RAPIDly moving target. Lancet 379:1680–1682

2. Beitelshees AL, Voora D, Lewis JP (2015) Personalized antiplatelet and anticoagulation therapy: applications and significance of pharmacogenomics. Pharmgenom Pers Med 8:43–61

3. Chae H, Kim M, Koh YS et al (2013) Feasibility of a microarray-based point-of-care CYP2C19 genotyping test for predicting clopidogrel on-treatment platelet reactivity. Biomed Res Int 2013:154073

4. Desai NR, Canestaro WJ, Kyrychenko P et al (2013) Impact of CYP2C19 genetic testing on provider prescribing patterns for antiplatelet therapy after acute coronary syndromes and percutaneous coronary intervention. Circ Cardiovasc Qual Outcomes 6:694–699

5. Haselmann V, Geilenkeuser WJ, Helfert S (2016) Thirteen years of an international external quality assessment scheme for genotyping: results and recommendations. Clin Chem 62:1084–1095

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of HLA variants and related SNPs with sarcoidosis and its phenotypes in the Greek patients;Gene;2024-11

2. Accuracy and technical characteristics of CYP2C19 point of care tests: a systematic review;Pharmacogenomics;2024-09-04

3. Association of Hla Variants and Related Snps with Sarcoidosis and its Phenotypes in the Greek Patients;2024

4. Advancing Pharmacogenomics from Single-Gene to Preemptive Testing;Annual Review of Genomics and Human Genetics;2022-08-31

5. Impacts of CYP2C19 genetic polymorphisms on bioavailability and effect on platelet adhesion of vicagrel, a novel thienopyridine P2Y 12 inhibitor;British Journal of Clinical Pharmacology;2020-06-17